Evaluation of Immunobiological Cold Chain Costs

Heuler Souza Andrade1, Maurílio de Souza Cazarim2, Valéria Conceição de Oliveira3

  • 1University of the State of Minas Gerais, Divinópolis, Minas Gerais, Brazil heulerandrade@gmail.com.

PubMed

Insights

This study determined the cost of the immunobiological cold chain (CC) in Brazil, finding that non-medical expenses and human resources significantly impact overall expenditure. Managers should prioritize these areas for efficient CC operations.

Area of Science:

  • Health Economics
  • Public Health
  • Supply Chain Management

Background:

  • Assessing the costs of the immunobiological cold chain (CC) is crucial but understudied.
  • Understanding resource allocation factors within the CC is essential for efficiency.

Purpose of the Study:

  • To determine the overall cost of the immunobiological cold chain.
  • To identify key cost drivers within the CC.

Main Methods:

  • A Health Economic Assessment was conducted in Minas Gerais, Brazil (2021-2022).
  • Analysis utilized micro- and macrocosting, considering the Public Health System perspective.
  • Included direct medical, non-medical, and indirect costs over a one-year period.

Main Results:

  • The total cost of the immunobiological CC was USD 20,014,545.
  • Non-medical direct costs constituted the largest portion (61.24%).
  • Human resources were the most influential cost factor (76.43%).

Conclusions:

  • Human resources and non-medical costs are the most significant drivers of CC expenses.
  • Managers should focus on these influential items to enhance CC efficiency and resource planning.

Related Concept Videos